Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Construction in Progress: 2019-2022

Historic Construction in Progress for Eton Pharmaceuticals (ETON) over the last 1 years, with Dec 2022 value amounting to $12,000.

  • Eton Pharmaceuticals' Construction in Progress was N/A to $12,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $12,000, marking a year-over-year change of. This contributed to the annual value of $12,000 for FY2022, which is N/A change from last year.
  • Eton Pharmaceuticals' Construction in Progress amounted to $12,000 in Q4 2022, which was down 0.00% from $12,000 recorded in Q1 2022.
  • In the past 5 years, Eton Pharmaceuticals' Construction in Progress ranged from a high of $873,000 in Q1 2019 and a low of $1,000 during Q3 2020.
  • For the 2-year period, Eton Pharmaceuticals' Construction in Progress averaged around $7,250, with its median value being $8,000 (2020).
  • Data for Eton Pharmaceuticals' Construction in Progress shows a maximum YoY plummeted of 99.54% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows Eton Pharmaceuticals' Construction in Progress stood at $9,000 in 2019, then tumbled by 66.67% to $1,000 in 2020, then reached $12,000 in 2022.
  • Its Construction in Progress stands at $12,000 for Q4 2022, versus $12,000 for Q1 2022 and $1,000 for Q3 2020.